ACHILLION PHARMACEUTICALS INC (ACHN) Stock Price, Quote, News and Overview
NASDAQ:ACHN - Nasdaq -
ACHN Quote, Performance and Key Statistics
6.76
+0.63 (+10.28%)
The current stock price of ACHN is 6.76 null. In the past month the price increased by 10.1%. In the past year, price increased by 201.79%.
About ACHN
Company Profile
ACHILLION PHARMACEUTICALS, INC. is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The company's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease -- HIV, hepatitis and resistant bacterial infections. Achillion sees significant competitive advantages in developing anti-infective drugs compared to developing drugs in other therapeutic areas. The emergence of drug resistance seen with current antiviral and antibacterial therapies creates a continuing need for new drugs, providing a large and growing potential business opportunity. In addition, development cycle times tend to be somewhat shorter in infectious disease than other therapeutic areas, and early drug development results tend to be more predictive of longer term results.
Company Info
ACHILLION PHARMACEUTICALS INC
300 GEORGE STREET
NEW HAVEN CT 06511
CEO: Joseph Truitt
Phone: 203-624-7000
ACHILLION PHARMACEUTICALS INC / ACHN FAQ
What is the stock price of ACHILLION PHARMACEUTICALS INC today?
The current stock price of ACHN is 6.76 null. The price increased by 10.28% in the last trading session.
What is the ticker symbol for ACHILLION PHARMACEUTICALS INC stock?
The exchange symbol of ACHILLION PHARMACEUTICALS INC is ACHN and it is listed on the Nasdaq exchange.
On which exchange is ACHN stock listed?
ACHN stock is listed on the Nasdaq exchange.
What is ACHILLION PHARMACEUTICALS INC worth?
ACHILLION PHARMACEUTICALS INC (ACHN) has a market capitalization of 946.72M null. This makes ACHN a Small Cap stock.
What are the support and resistance levels for ACHILLION PHARMACEUTICALS INC (ACHN) stock?
ACHILLION PHARMACEUTICALS INC (ACHN) has a support level at 6.22. Check the full technical report for a detailed analysis of ACHN support and resistance levels.
Should I buy ACHILLION PHARMACEUTICALS INC (ACHN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ACHN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ACHN, evaluating the profitability, health, valuation and growth aspects
- ACHILLION PHARMACEUTICALS INC (ACHN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ACHILLION PHARMACEUTICALS INC (ACHN) Sales and EPS estimates to see what analysts future expectations are.
- ACHILLION PHARMACEUTICALS INC (ACHN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ACHILLION PHARMACEUTICALS INC (ACHN) Insider and Institutional Ownership to learn about the owners and their transactions.
- ACHILLION PHARMACEUTICALS INC (ACHN) Stock Chart to make your own analysis
- ACHILLION PHARMACEUTICALS INC (ACHN) Latest news and press-releases to stay up to date.
Does ACHILLION PHARMACEUTICALS INC (ACHN) stock pay dividends?
ACHN does not pay a dividend.
What is the Price/Earnings (PE) ratio of ACHILLION PHARMACEUTICALS INC (ACHN)?
ACHILLION PHARMACEUTICALS INC (ACHN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).
ACHN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ACHN. When comparing the yearly performance of all stocks, ACHN is one of the better performing stocks in the market, outperforming 98.56% of all stocks.
ACHN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ACHN. ACHN has a great financial health rating, but its profitability evaluates not so good.
ACHN Financial Highlights
Over the last trailing twelve months ACHN reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS increased by 3.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.55% | ||
| ROE | N/A | ||
| Debt/Equity | 0.01 |
ACHN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 40% to ACHN. The Buy consensus is the average rating of analysts ratings from 2 analysts.